Search results
J&J-backed Bright Peak secures $90m to advance immunoconjugate programme
Pharmaceutical Technology via Yahoo Finance· 1 day agoBright Peak Therapeutics has raised $90m in a Series C financing round as the biotech looks to make...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 6 days agoA month has gone by since the last earnings report for Prothena (PRTA). Shares have lost about 1.5%...
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 3 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...
Hypertrophic Cardiomyopathy 101: What every student-athlete should know
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoHeart conditions may be more often associated with older individuals, but you might be surprised to...
Taye Diggs’ Champions Wellness Campaign After Sister Diagnosed With Schizophrenia
Black America Web· 3 days agoTaye Diggs is shining a spotlight on schizophrenia after his younger sister Christian was diagnosed...
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
InvestorPlace· 3 days agoThe Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
InvestorPlace· 5 days agoFor many investors, especially those who are just building a portfolio, undervalued stocks under $50...
Geron Shares Surge After U.S. FDA Approves Blood Disorder Drug
US News & World Report· 6 days agoThe injectable drug will compete with Bristol Myers Squibb's Reblozyl, which received a label expansion green light by the regulator last year for the same disease indication. California-based ...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 3 days agoDive Brief: Biotechnology startup Alumis on Friday outlined plans for an initial public offering...